bioXclusters
Life sciences organisations–a key sector in Europe working on meeting citizens' social and environmental needs–put together their competencies to develop a world-class cluster, successful on the global market.
Four leading biotechnology and healthcare clusters with more than 1700 companies from the fields of drug development, healthcare and medical technology unite their knowledge and skills in theBioX4Clusters. Together, they develop a sustainable internationalisation strategy by inviting foreign experts, organising training sessions, developing strategies for individual target markets and a European Life Sciences Taskforce in China. The project focus will be on the USA, Brazil and China, with the aim of expanding to other partner countries in the long run.
The BioX4Clusters work with innovative approaches in cutting-edge scientific research projects, maintaining a dynamic environment for facing the current market and patients' needs.
News:
Report on the "EU‐Japan Cluster Matchmaking Event" The Strategic Cluster Partnership (ESCP) for Personalised Healthcare
The EU‐Japan Matchmaking Event was organized as a parallel session during BIO‐Europe, the largest European biotech healthcare trade show, which took place in Frankfurt, Germany, 3‐6 November 2014.
bioXclusters started as a European initiative, uniting four European bioregions with one single overarching aim ‐ increasing the competitiveness of SMEs by supporting the internationalization process and by creating a single European entry point for global players in the life sciences health sector. The four clusters involved are Biocat (Catalonia, Spain), BioM (Bavaria, Germany), bioPmed (Piemonte, Italy) and Lthe EU‐Japan Matchmaking Event was organized as a parallel session during BIO‐Europe, the largest European biotech healthcare trade show, which took place in Frankfurt, Germany, 3‐6 November 2014.yonbiopole (Rhône‐Alpes, France).
More information is available in the attached files: :
- mission report
- programme
- mainstreaming examples
- participants
bioXcluster: EU‐Japan Cluster Matchmaking Event
Make use of this great possibility to learn about the strenghts of Japanese life science landscapes and clusters in the health care sector
The EU‐Japan Cluster Matchmaking Event – financially supported by the European Commission (http://www.clustercollaboration.eu/) – is taking place at Bio Europe in Frankfurt (Germany) on November, 3rd. It provides the perfect opportunity to gain an overview of the strengths of the Japanese life sciences landscapes and clusters in the health care sector.
bioXclusters is a European initiative, uniting 4 European bioregions with one single overarching aim ‐ increasing the competitiveness of SMEs by supporting the internationalization process and by creating a single European entry point for global players in the life sciences sector. The 4 clusters involved are Biocat (Catalonia, Spain), BioM (Bavaria, Germany), bioPmed (Piemonte, Italy) and Lyonbiopole (Rhône‐Alpes, France).
Speakers from four leading Japanese life science clusters and from Japan Bioindustry Association (JBA) will present the vast array of opportunities that the Japanese pharma and health market offers to European companies.
For more information please find attached the Agenda of EU-Japan Matchmaking Event Bio-Europe2014.
Biotech and Life Science Clusters from around the World meet in San Diego
Global Cluster Biomarker Programme
The Global Cluster Biomarker Programme brings together clusters across the world to build a unique portfolio of SMEs, researchers and collaborations that drive biomarker integration into healthcare and life sciences.
Activities of the programme are free of charge and include:
-
Creation of a dedicated biomarker SME and researcher directory – quality controlled, biomarker-focussed resource from over 50 clusters worldwide. Published online and in print on June 25 as part of BIO Convention San Diego (see below)
-
2 hour workshop at the BIO Convention, San Diego on June 25, 1030 – 1230 (BIO Theatre) –selected biomarker SME presentations from contributing clusters
-
Networking of directory SMEs and researchers for global partnering through selected biomarker conferences, e.g. creation of panel discussions, workshops and activities targeted at directory participants.
Are you eligible?
If you are a cluster that has active biomarker SMEs, then they are welcome to take part in the Global Cluster Biomarker Directory, if they meet the following criteria:
-
Direct biomarker activities – either as core focus or actively used within to deliver a core strategy, whether as a product or service
-
Demonstration of named biomarker experience through description of activities, projects, collaborations, publications and patents
How to get your cluster involved?
-
Contact the Council of European BioRegions on info [at] cebr.net for the biomarker SME template and example profiles
-
The deadline for inclusion in the online directory for launch at BIO is June 20 2014, however the directory is a long term programme and profiles can be added at any time if they meet the entry criteria.
For further information, confirm eligibility or submit a profile
-
Contact Claire Skentelbery through info [at] cebr.net
Bioxclusters USA Mission report
Outputs and Recommendations
BioXclusters partners, along with some European SMEs, went to Boston (Massachusetts) last October 2013. Read the report we have produced with the description of the visits and information about the life sciences market.
The objective of the mission in Boston was to discover and detect key entry points of the biotech and medtech market in the USA and collaboration opportunities with the different organizations visited. The USA represents a key market in life sciences, and notably for Personalized Healthcare. With a life sciences sector weighting $61 billion and counting about 1.455 companies, among which 300 quoted in stock exchange, the USA is without any doubt the top-leading economy on this market.
The life sciences is indeed one of the most dynamic sector of the American economy were not less than $30 billion were invested for R&D in 2010. The American life sciences market alone accounts for 70% of the world turnover and for 15 % of the total sales of the biotechnologies market.
Please find attached the Report-USA mission 2013.
How to go International: Lessons from the bioXcluster pilot project
Strengthening and promoting the international competitiveness of life sciences SMEs beyond Europe are essential tasks in an increasingly globalised environment. One main argument for this is the observed growth effects of cross-border venturing, and the "demonstrated capacity of SMEs to drive economic development at national, regional, and global levels" (European Commission, 2007).
Meeting the requirements of the accelerated globalisation process that markets have experienced over the last 30 years, and designing tailor-made internationalisation strategies, are crucial goals for sectors such as the biotechnology, biomedicine and medical technology, which are by definition global.
-
Invitation of foreign experts and delivery of workshops with them in Europe. The approach was double-sized, i.e supporting the internationalisation of SMEs and promoting the attractiveness of the bioXclusters regions vis-à-vis the foreign partner.
-
Missions to the target markets, co-organised thanks to the internationalisation agency support.
-
Becoming an information and support hub for the SMEs of the participating regions. Country reports and market information were provided continuously through the bioXclusters blog www.bioxclusters.eu
The bioXcluster consortium has summarized its findings and lessons learned in a report that can be found attached (Handbook - bioXclusters).
Internationalisation in life sciences: the role of clustersInternationalisation, especially in China, is considered sometimes as an issue by SMEs and clusters. In life science it is not an option. The activity of the sector cannot be constricted to national borders.
The market is global and the competition is global. SMEs are not always sure about how to face other markets that can offer big opportunities but also present big challenges. In such scenario which is the role of clusters?
Internationalization in Life Sciences (attached)- the whole text by Fabrizio Conicella
Documents:
Short Description
bioXclusters Final report
bioXclusters Handbook on Cluster Intrnationalization
Country resources USA:
Country report 2013 (report USA mission 2013 - attached)
Global Liefe Science Report 2012
State Bioscience Industry Development 2012 (battelle-bio_2012_industry_development, attached)
National Bioeconomy Blueprint (attached)
Country Resources Brazil
Brazil Mission Report 2012 (report-brazil-mission file, attached)
Biominas Presentation (attached)
Life Science in Latin America (eduardo-soares_brazil-opportunities-april-2012, attached)
Country Resources China
China Mission Report 2013 (report China mission, attached)
Country Report (country report China, attached)